Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cadre Holdings, Inc.CDRE · Entity 4819 | CHIEF FINANCIAL OFFICER | June 16, 2026 | June 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cadre Holdings, Inc.
Report date June 16, 2026 · Filed June 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 48,500 |
Reported balance
After 2026-06-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-16 · Grant · Acquired 48,500 · Balance 48,500 F1: Represents an award of restricted stock units granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan (the "Plan"), consisting of 48,500 restricted stock units relating to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"). The restricted stock units will vest only if, on or before June 16, 2033, the Common Stock achieves a volume-weighted average trading price ("VWAP") of at least $60.00 per share over a 20 consecutive trading day measurement period, with any such vesting to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 69,500 |
Reported balance
After 2026-06-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-16 · Grant · Acquired 69,500 · Balance 69,500 F2: Represents an award of restricted stock units granted under the Plan, consisting of 69,500 restricted stock units relating to shares of the Issuer's Common Stock. The restricted stock units will vest only if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $80.00 per share over a 20 consecutive trading day measurement period, with any such vesting to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant. |
| Stock Option (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $28.75 · Expires 2033-06-16 | Direct | 92,500 |
Reported balance
After 2026-06-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-16 · Grant · Acquired 92,500 · Balance 92,500 F3: The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 92,500 shares of the Issuer's Common Stock will vest and become exercisable only if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $60.00 per share over a 20 consecutive trading day measurement period, with any such vesting and exercisability to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant. |
| Stock Option (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $28.75 · Expires 2033-06-16 | Direct | 115,000 |
Reported balance
After 2026-06-16 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-16 · Grant · Acquired 115,000 · Balance 115,000 F4: The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 115,000 shares of the Issuer's Common Stock will vest and become exercisable only if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $80.00 per share over a 20 consecutive trading day measurement period, with any such vesting and exercisability to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan (the "Plan"), consisting of 48,500 restricted stock units relating to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"). The restricted stock units will vest only if, on or before June 16, 2033, the Common Stock achieves a volume-weighted average trading price ("VWAP") of at least $60.00 per share over a 20 consecutive trading day measurement period, with any such vesting to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant.
F2: Represents an award of restricted stock units granted under the Plan, consisting of 69,500 restricted stock units relating to shares of the Issuer's Common Stock. The restricted stock units will vest only if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $80.00 per share over a 20 consecutive trading day measurement period, with any such vesting to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant.
F3: The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 92,500 shares of the Issuer's Common Stock will vest and become exercisable only if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $60.00 per share over a 20 consecutive trading day measurement period, with any such vesting and exercisability to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant.
F4: The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 115,000 shares of the Issuer's Common Stock will vest and become exercisable only if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $80.00 per share over a 20 consecutive trading day measurement period, with any such vesting and exercisability to occur upon the later to occur of the date such VWAP condition is achieved and the third anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 09, 2023 Filed Mar 13, 2023 20:15 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Tax withholdingCommon Stock | 1,304 | $21.77 | $28,388.08 |
DisclosureSEC source: 0001104659-23-031775 · tm238945-1_4seq1.xml · nonDerivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,727 F2 · shares: Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Browers as a result of the vesting on March 9, 2023 of a portion of the Restricted Stock Award. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 20:15 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionCommon Stock, par value $0.0001 per share ("Common Stock") | 2,919 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-031775 · tm238945-1_4seq1.xml · nonDerivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,031 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Comprised of a restricted stock award previously granted on March 9, 2022 under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 8,755 restricted shares of Common Stock. 2,919 restricted shares of Common Stock vested and became non-forfeitable on March 9, 2023 and 2,918 restricted shares of Common Stock will vest and become non-forfeitable on each of March 9, 2024 and March 9, 2025. Read SEC document |
| March 18, 2022 Filed Mar 22, 2022 20:16 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionPhantom Stock · Derivative | 55,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-036574 · tm2210067d2_4seq1.xml · derivative · entry 3 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,666 Underlying: Common Stock · 55,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 9, 2022, the Reporting Person was granted a phantom stock award under the Safariland Group Amended and Restated 2021 Phantom Restricted Share Plan consisting of 166,000 shares of phantom stock. Each share of phantom stock is the economic equivalent of one share of Common Stock. 55,334 shares of phantom stock vest and become non-forfeitable on March 18, 2022, and 55,333 shares of phantom stock vest and become non-forfeitable on March 18, 2023 and March 18, 2024. F1 · derivative.exercise_date: On March 9, 2022, the Reporting Person was granted a phantom stock award under the Safariland Group Amended and Restated 2021 Phantom Restricted Share Plan consisting of 166,000 shares of phantom stock. Each share of phantom stock is the economic equivalent of one share of Common Stock. 55,334 shares of phantom stock vest and become non-forfeitable on March 18, 2022, and 55,333 shares of phantom stock vest and become non-forfeitable on March 18, 2023 and March 18, 2024. F1 · derivative.expiration_date: On March 9, 2022, the Reporting Person was granted a phantom stock award under the Safariland Group Amended and Restated 2021 Phantom Restricted Share Plan consisting of 166,000 shares of phantom stock. Each share of phantom stock is the economic equivalent of one share of Common Stock. 55,334 shares of phantom stock vest and become non-forfeitable on March 18, 2022, and 55,333 shares of phantom stock vest and become non-forfeitable on March 18, 2023 and March 18, 2024. Read SEC document |
| March 18, 2022 Filed Mar 22, 2022 20:16 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Tax withholdingCommon Stock | 21,844 | $25.05 | $547,192.20 |
DisclosureSEC source: 0001104659-22-036574 · tm2210067d2_4seq1.xml · nonDerivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,112 Read SEC document |
| March 18, 2022 Filed Mar 22, 2022 20:16 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Exercise / conversionCommon Stock, $.0001 par value ("Common Stock") | 55,334 | $25.05 | $1,386,116.70 |
DisclosureSEC source: 0001104659-22-036574 · tm2210067d2_4seq1.xml · nonDerivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 21:16 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | Tax withholdingCommon Stock | 3,649 | $25.36 | $92,538.64 |
DisclosureSEC source: 0001104659-22-035111 · tm229649-2_4seq1.xml · nonDerivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,622 Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 21:16 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | GrantCommon Stock, $.0001 par value ("Common Stock") | 9,271 | $25.36 | $235,112.56 |
DisclosureSEC source: 0001104659-22-035111 · tm229649-2_4seq1.xml · nonDerivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,271 F1 · shares: Represents the settlement in shares of Common Stock, at the election of the Issuer's Board of Directors, of a cash bonus opportunity that vested on March 15, 2022, granted pursuant the Safariland Group Long-Term Incentive Plan. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:31 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | GrantPhantom Stock · Derivative | 166,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-032912 · tm228848-2_4seq1.xml · derivative · entry 3 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,000 Underlying: Common Stock · 166,000 shares Expires not disclosed F3 · derivative.exercise_price: Phantom stock award granted under the Safariland Group Amended and Restated 2021 Phantom Restricted Share Plan consisting of 166,000 shares of phantom stock. Each share of phantom stock is the economic equivalent of one share of Common Stock. 55,334 shares of phantom stock will vest and become non-forfeitable on March 18, 2022 and 55,333 shares of phantom stock will vest and become non-forfeitable on each of March 18, 2023 and March 18, 2024. F3 · derivative.exercise_date: Phantom stock award granted under the Safariland Group Amended and Restated 2021 Phantom Restricted Share Plan consisting of 166,000 shares of phantom stock. Each share of phantom stock is the economic equivalent of one share of Common Stock. 55,334 shares of phantom stock will vest and become non-forfeitable on March 18, 2022 and 55,333 shares of phantom stock will vest and become non-forfeitable on each of March 18, 2023 and March 18, 2024. F3 · derivative.expiration_date: Phantom stock award granted under the Safariland Group Amended and Restated 2021 Phantom Restricted Share Plan consisting of 166,000 shares of phantom stock. Each share of phantom stock is the economic equivalent of one share of Common Stock. 55,334 shares of phantom stock will vest and become non-forfeitable on March 18, 2022 and 55,333 shares of phantom stock will vest and become non-forfeitable on each of March 18, 2023 and March 18, 2024. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:31 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | GrantStock Option (right to purchase) · Derivative | 31,836 | $0.00 Strike: $23.45 | $0.00 |
DisclosureSEC source: 0001104659-22-032912 · tm228848-2_4seq1.xml · derivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,836 Underlying: Common Stock · 31,836 shares Expires 2032-03-09 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 10,612 shares of the Issuer's Common Stock will vest and become exercisable on each of March 9, 2023, March 9, 2024 and March 9, 2025. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:31 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | GrantCommon Stock, par value $0.0001 per share ("Common Stock") · Derivative | 8,755 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-032912 · tm228848-2_4seq1.xml · derivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,755 Underlying: Common Stock · 8,755 shares Expires not disclosed F1 · derivative.exercise_price: Comprised of a restricted stock award granted under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 8,755 restricted shares of Common Stock. 2,919 restricted shares of Common Stock will vest and become non-forfeitable on March 9, 2023 and 2,918 restricted shares of Common Stock will vest and become non-forfeitable on each of March 9, 2024 and March 9, 2025. F1 · derivative.exercise_date: Comprised of a restricted stock award granted under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 8,755 restricted shares of Common Stock. 2,919 restricted shares of Common Stock will vest and become non-forfeitable on March 9, 2023 and 2,918 restricted shares of Common Stock will vest and become non-forfeitable on each of March 9, 2024 and March 9, 2025. F1 · derivative.expiration_date: Comprised of a restricted stock award granted under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 8,755 restricted shares of Common Stock. 2,919 restricted shares of Common Stock will vest and become non-forfeitable on March 9, 2023 and 2,918 restricted shares of Common Stock will vest and become non-forfeitable on each of March 9, 2024 and March 9, 2025. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 21:15 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | GrantCommon Stock, par value $0.0001 per share ("Common Stock") · Derivative | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-025170 · tm226894-1_4.xml · derivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2031-11-08 F1 · derivative.exercise_price: Comprised of a restricted stock award granted under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 150,000 restricted shares of Common Stock all of which will vest if on or before November 8, 2031 both (i) the Fair Market Value of the Company's Common Stock shall have equaled or exceeded $40.00 per share for twenty consecutive trading days, and (ii) the Recipient having being continuously employed by the Company until November 8, 2026. F1 · derivative.exercise_date: Comprised of a restricted stock award granted under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 150,000 restricted shares of Common Stock all of which will vest if on or before November 8, 2031 both (i) the Fair Market Value of the Company's Common Stock shall have equaled or exceeded $40.00 per share for twenty consecutive trading days, and (ii) the Recipient having being continuously employed by the Company until November 8, 2026. Read SEC document |
| November 08, 2021 Filed Feb 14, 2022 21:13 UTC | Cadre Holdings, Inc. CDRE · Entity 4819 | PurchaseCommon Stock, par value $0.0001 per share ("Common Stock") | 15,000 | $13.00 | $195,000.00 |
DisclosureSEC source: 0001104659-22-022799 · tm225744-2_5.xml · nonDerivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · kind: This filing is being made to reflect information that was inadvertently not filed on a Form 4 by the Reporting Person within the prescribed time period. F2 · kind: Reflects shares of Common Stock purchased by the Reporting Person in a directed share program in connection with the Issuer's initial public offering which closed on November 8, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.